The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Jiangsu Hengrui Medicine
Anti-programmed death-1 antibody SHR-1210 (S) combined with apatinib (A) for advanced hepatocellular carcinoma (HCC), gastric cancer (GC) or esophagogastric junction (EGJ) cancer refractory to standard therapy: A phase 1 trial.
 
Jian-Ming Xu
No Relationships to Disclose
 
Yun Zhang
No Relationships to Disclose
 
Ru Jia
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Rongrui Liu
No Relationships to Disclose
 
Gairong Zhang
No Relationships to Disclose
 
Chuanhua Zhao
No Relationships to Disclose
 
Yaoyue Zhang
No Relationships to Disclose
 
Jianjun Zou
No Relationships to Disclose
 
Quanren Wang
Employment - Jiangsu Hengrui Medicine